Center for Healthcare Policy and Research and Department of Family & Community Medicine, University of California at Davis, 4860 Y Street, Suite 2300, Sacramento, CA 95817, USA.
BMC Health Serv Res. 2010 Mar 17;10:68. doi: 10.1186/1472-6963-10-68.
Whether patient socio-demographic characteristics (age, sex, race/ethnicity, income, and education) are independently associated with failure to receive indicated statin therapy and/or to achieve low density lipoprotein cholesterol (LDL-C) therapy goals are not known. We examined socio-demographic factors associated with a) eligibility for statin therapy among those not on statins, and b) achievement of statin therapy goals.
Adults (21-79 years) participating in the United States (US) National Health and Nutrition Examination Surveys, 1999-2006 were studied. Statin eligibility and achievement of target LDL-C was assessed using the US Third Adult Treatment Panel (ATP III) on Treatment of High Cholesterol guidelines.
Among 6,043 participants not taking statins, 10.4% were eligible. Adjusted predictors of statin eligibility among statin non-users were being older, male, poorer, and less educated. Hispanics were less likely to be eligible but not using statins, an effect that became non-significant with adjustment for language usually spoken at home. Among 537 persons taking statins, 81% were at LDL-C goal. Adjusted predictors of goal failure among statin users were being male and poorer. These risks were not attenuated by adjustment for healthcare access or utilization.
Among person's not taking statins, the socio-economically disadvantaged are more likely to be eligible and among those on statins, the socio-economically disadvantaged are less likely to achieve statin treatment goals. Further study is needed to identify specific amenable patient and/or physician factors that contribute to these disparities.
患者的社会人口统计学特征(年龄、性别、种族/民族、收入和教育程度)是否与未能接受推荐的他汀类药物治疗以及未能达到低密度脂蛋白胆固醇(LDL-C)治疗目标独立相关尚不清楚。我们研究了与以下方面相关的社会人口学因素:a)未服用他汀类药物的患者中他汀类药物治疗的资格,以及 b)他汀类药物治疗目标的实现。
研究对象为参加了美国(US)国家健康和营养调查(NHANES)1999-2006 年调查的成年人(21-79 岁)。使用美国第三成人治疗专家组(ATP III)关于高胆固醇治疗指南评估他汀类药物的资格和 LDL-C 目标的达标情况。
在 6043 名未服用他汀类药物的参与者中,有 10.4%符合他汀类药物治疗的条件。在未服用他汀类药物的患者中,调整后的他汀类药物治疗资格预测因素为年龄较大、男性、经济条件较差和受教育程度较低。西班牙裔患者不太可能符合他汀类药物治疗条件,但他们不使用他汀类药物,这种影响在调整在家中常用语言后变得不显著。在 537 名服用他汀类药物的患者中,有 81%达到 LDL-C 目标。调整后的他汀类药物使用者未能达到目标的预测因素为男性和经济条件较差。这些风险在调整医疗保健的可及性或利用率后并没有减弱。
在未服用他汀类药物的人群中,社会经济地位较低的人更有可能符合他汀类药物治疗的条件,而在服用他汀类药物的人群中,社会经济地位较低的人更不可能达到他汀类药物治疗的目标。需要进一步研究以确定导致这些差异的具体可改善的患者和/或医生因素。